Skip to main content

Animations

MJFF Publications

6141 - 6150 of 9033 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2024
  • 2023
  • 2021
  • 2024
  • 2023
  • 2024
  • 2024
  • Summary Details
    OPEN
    Title: Fast, multicolour optical sectioning over extended fields of view with patterned illumination and machine learning
    Journal Name: Biomedical Optics Express
    Publisher: Optica Publishing Group
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1364/boe.510912
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Genetic analysis and natural history of Parkinson’s disease due to the LRRK2 G2019S variant
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awae073
    Citation Count: 48
  • Summary Details
    OPEN
    Title: An Inducible Luminescent System to Explore Parkinson’s Disease-Associated Genes
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms25179493
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Selection of DNA aptamers that prevent the fibrillization of α-synuclein protein in cellular and mouse models
    Journal Name: Molecular Therapy - Nucleic Acids
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.omtn.2024.102251
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Dopamine transporter and synaptic vesicle sorting defects underlie auxilin-associated Parkinson’s disease
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.celrep.2023.112231
    Citation Count: 61
  • Summary Details
    OPEN
    Title: Blood–brain barrier permeability in Parkinson’s disease patients with and without dyskinesia
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00415-021-10411-1
    Citation Count: 15
  • Summary Details
    OPEN
    Title: The hexosamine biosynthetic pathway rescues lysosomal dysfunction in Parkinson’s disease patient iPSC derived midbrain neurons
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-024-49256-3
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Large multi-ethnic genetic analyses of amyloid imaging identify new genes for Alzheimer disease
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-023-01563-4
    Citation Count: 53
  • Summary Details
    OPEN
    Title: Changes in Oxidised Phospholipids in Response to Oxidative Stress in Microtubule-Associated Protein Tau (MAPT) Mutant Dopamine Neurons
    Journal Name: Antioxidants
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/antiox13050508
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Identification and structural characterization of small molecule inhibitors of PINK1
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-024-58285-3
    Citation Count: 14
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.